|
MICRO THERAPEUTICS, INC. DBA EV3 PIPELINE FLEX W/SHIELD TECHNOLOGY; INTRACRANIAL ANEURYSM FLOW DIVERTER
|
Back to Search Results |
|
| Model Number |
PED2-450-16 |
| Medical Device Problem Code |
Activation Failure (3270)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
02/12/2026
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
Medtronic received a report of a pipeline device that failed to open distally.The patient was undergoing surgery for treatment of a saccular, unruptured aneurysm located in the left ophthalmic segment.The landing zone (artery size) was 4.0mm distally and 4.4mm proximally.It was noted the patient's vessel tortuosity was minimal.Dapt (dual antiplatelet treatment) was administered with a platelet reactivity units (pru) level of 170.The angiographic post procedure result was retention of contrast agent within the aneurysm, while blood flow in the parent artery and distal vessels was normal.It was reported that the phenom27 shapable microcatheter was placed to the left m2 segment.Based on the vessel diameter at the aneurysm site, a 4.5-16 stent was selected; both the inner and outer packaging were intact.The flow-diverting mesh stent was hydrated and then was delivered through the phenom27.After positioning the stent, multiple attempts were made to deploy the stent, but the stent tip could not be opened and the stent could not be deployed.The stent was then removed and replaced with a 4.5-14 stent, which was deployed successfully, and the procedure was completed.It was noted that the failure to open occurred in the distal section of the device.The pipeline had less than 50% deployed when it failed to open and it was not positioned in a bend.The pipeline was not used for an indication that is not approved (off-label).It was indicated that all devices were prepared as per the instructions for use (ifu), and no patient symptoms or further complications were reported as a result of this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
Additional information was received that the cause of the event was not determined.The device was removed from the patient.
|
| |
|
Additional Manufacturer Narrative
|
|
B5: additional information added to event summary.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
H3 product analysis: ¿ drawing(s) referenced: n/a ¿ as found condition: the pipeline flex shield was returned inside the inner pouch, biohazard bag, and shipping box.¿ visual inspection/damage location details: the distal and proximal dps restraints were intact, and the dps sleeves showed no signs of damage.Both the distal hypotube and the ptfe shrink tubing were also intact, with no signs of elongation.The distal end and middle section of the braid were not open and frayed.The proximal end of the braid appeared to be open and frayed.The pushwire showed no bends, and there were no defects in the tip coil, distal marker, re-sheathing marker, re-sheathing pad, or proximal bumper.No other anomalies were observed.¿ testing/analysis: n/a ¿ conclusion: based on the returned device, the customer report of "failure to open at the distal" was confirmed, as the distal end of the braid was not opened and frayed.Additionally, the middle section of the braid was also not open and frayed.The cause of the failure to open could not be determined.Possible causes of failure to open include vessel tortuosity, damage to the braid, or deployment of the braid in a bend of the vessel.The customer indicated that the vessel tortuosity was minimal and the braid was not positioned in the vessel bend, which rules them out as possible causes.In this event, the damaged braid contributed to the failure to open.Such damage can occur from resheathing the braid more than twice, over-manipulation, improper deployment techniques, pushing or pulling the delivery wire against resistance, or deploying or resheathing the braid against resistance.However, the cause of the braid damage could not be determined.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|
|
|